US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 7.500
- -0.120-1.57%
Close Nov 22 16:00 ET
- 7.612
- +0.112+1.49%
Post 20:01 ET
54.72MMarket Cap-571P/E (TTM)
7.600High7.405Low46.01KVolume7.500Open7.620Pre Close346.95KTurnover1.01%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.41P/B34.08MFloat Cap5.20252wk Low--Dividend TTM4.54MShs Float363.268Historical High--Div YieldTTM2.56%Amplitude5.200Historical Low7.540Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Kezar Life Sciences Stock Forum
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet